News

Arnold & Porter hosted a complimentary, full-day program on the current state of federal and state investigations and enforcement activity involving the pharmaceutical and medical device industries. High-level former government enforcement attorneys offered their insights into current and developing government theories, and participants heard from experienced civil, criminal and regulatory enforcement counsel on how to anticipate and avoid enforcement, and drive successful resolutions when enforcement does occur.

Additional insights were provided by Andrew Bruck, Executive Assistant Attorney General, and David Eskew, Chief, Health Care & Government Fraud Unit, at the United States Attorney's Office, District of New Jersey.

Topics Included:

  • False Claims Act enforcement developments and trends
  • Key risk areas including recent DOJ inquiries involving pricing and patient assistance programs, and developing state attorneys general actions
  • Global anti-corruption investigations, defense and compliance
  • Antitrust enforcement by the FTC and DOJ
  • Current regulatory enforcement risks and trends

» View Event Speakers

Meet the Speakers

Marcus A. Asner
Partner
Arnold & Porter
Mahnu V. Davar
Partner
Arnold & Porter
Joshua M. Davis
Partner
Arnold & Porter
Debbie Feinstein
Partner
Arnold & Porter
Paul J. Fishman
Partner
Arnold & Porter
Jeffrey L. Handwerker
Partner
Arnold & Porter
Suneeta Hazra
Partner
Arnold & Porter
Murad Hussain
Partner
Arnold & Porter
Daniel A. Kracov
Partner
Arnold & Porter
C. Scott Lent
Partner
Arnold & Porter
Craig D. Margolis
Partner
Arnold & Porter
Manvin S. Mayell
Partner
Arnold & Porter
John N. Nassikas
Partner
Arnold & Porter
Kirk Ogrosky
Partner
Arnold & Porter
Sonia Kuester Pfaffenroth
Partner
Arnold & Porter
Paula Ramer
Partner
Arnold & Porter
Michael A. Rogoff
Partner
Arnold & Porter
Debra E. Schreck
Partner
Arnold & Porter
John Tan
Partner
Arnold & Porter
Subscribe
Subscribe Link

Email Disclaimer